PDE5 Inhibitors Working Group: Members
Katerina Mastovska, Covance (Chair)
Joe Betz, NIH
Anton Bzhelyansky, USP
Teresa Cain, FDA
Jana Hildreth Blaze Science Industries
Anatoly Chlenov, PerkinElmer
John Edwards, Process NMR
Todd Koch Pfizer
,
David Kennedy, Phenomenex
James Neal‐Kababick, Flora Research
,
Alexander Krynitsky, FDA
Stephen Lock, AB SCIEX
Melissa Phillips, NIST
Steve Royce, Agilent
John Travis NSF International
Elisa Nickum, FDA
Catherine Rimmer, NIST
Brian Schaneberg Starbucks
,
Lukas Vaclavik, FDA
Jerry Zweigenbaum, Agilent
,
Olga Shimelis, Supelco
Garrett Zielinski, Covance